Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis
Status:
Completed
Trial end date:
2019-11-25
Target enrollment:
Participant gender:
Summary
A multicenter, randomized, single-blind, parallel-controlled clinical study to evaluate the
efficacy and safety of boroda supramolecular active zinc in the treatment of scalp psoriasis.
Main objective:：Compare the efficacy of boroda supramolecular active zinc and capotetriol
liniment in the treatment of scalp psoriasis Secondary objective: To observe the safety of
boroda supramolecular active zinc in the treatment of subjects with scalp psoriasis